Last Updated:

Saturday, December 3, 2022

4:26 PM

USA

CytoDyn

CytoDyn is a biotechnology company focused on developing innovative treatments for multiple therapeutic indications based on Leronlimab (PRO 140).

CytoDyn is a biotechnology company focused on developing innovative treatments for multiple therapeutic indications based on Leronlimab (PRO 140).

Newsroom